XML 38 R26.htm IDEA: XBRL DOCUMENT v3.21.2
REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)
 6 Months Ended
Jun. 30, 2021
Revenue from Contract with Customer [Abstract]  
Schedule of Changes in Contract Assets and Contract Liabilities
The following table summarizes the changes in the contract asset and liability balances for the six months ended June 30, 2021:
Contract Asset
Contract asset, January 1, 2021$7,430 
Transferred to trade receivable of contract asset included in beginning of the year contract asset(7,430)
Contract asset, net of transferred to trade receivables on contracts during the period7,952 
Contract asset, June 30, 2021
$7,952 
Contract Liability
Contract liability, January 1, 2021$11,961 
Recognition of revenue included in beginning of year contract liability(2,838)
Contract liability, net of revenue recognized on contracts during the period3,102 
Foreign currency translation(125)
Contract liability, June 30, 2021
$12,100 
Schedule of Disaggregation of Revenue
The following table presents revenues disaggregated by the major sources of revenues for the three and six months ended June 30, 2021 and 2020 (dollar amounts in thousands):
Three Months Ended June 30, 2021Three Months Ended June 30, 2020Six Months Ended June 30, 2021Six Months Ended June 30, 2020
Neurosurgery$202,600 $141,430 $391,854 $326,373 
Instruments54,237 28,348 106,224 74,845 
Total Codman Specialty Surgical256,837 169,778 498,078 401,218 
Wound Reconstruction and Care(2)
102,616 56,291 191,314 128,558 
Extremity Orthopedics(1)
— 11,162 — 32,634 
Private Label30,539 21,434 60,671 50,579 
Total Tissue Technologies133,155 88,887 251,985 211,771 
Total revenue$389,992 $258,665 $750,063 $612,989 
(1) On January 4, 2021, the Company completed its previously announced sale of its Extremity Orthopedics business. In conjunction with the sale of this business, the Company rebranded the Orthopedics and Tissue Technologies segment as Tissue Technologies in the first quarter of 2021. See Note 2. Acquisitions and Divestitures, for details.
(2) See Note 2. Acquisitions and Divestitures, for details around the ACell Inc. Acquisition.